• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

琥珀酸半醛脱氢酶缺乏症(一种γ-氨基丁酸代谢紊乱疾病)中诱发的皮质β和γ活动以及神经元同步性降低。

Reduced evoked cortical beta and gamma activity and neuronal synchronization in succinic semialdehyde dehydrogenase deficiency, a disorder of γ-aminobutyric acid metabolism.

作者信息

Papadelis Christos, Ntolkeras Georgios, Tokatly Latzer Itay, DiBacco Melissa L, Afacan Onur, Warfield Simon, Shi Xutong, Roullet Jean-Baptiste, Gibson K Michael, Pearl Phillip L

机构信息

Jane and John Justin Institute for Mind Health, Cook Children's Health Care System, Fort Worth, TX 76104, USA.

School of Medicine, Texas Christian University, Fort Worth, TX 76129, USA.

出版信息

Brain Commun. 2023 Oct 25;5(6):fcad291. doi: 10.1093/braincomms/fcad291. eCollection 2023.

DOI:10.1093/braincomms/fcad291
PMID:37953848
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10636566/
Abstract

Succinic semialdehyde dehydrogenase deficiency is a rare autosomal recessively inherited metabolic disorder of γ-aminobutyric acid catabolism manifested by intellectual disability, expressive aphasia, movement disorders, psychiatric ailments and epilepsy. Subjects with succinic semialdehyde dehydrogenase deficiency are characterized by elevated γ-aminobutyric acid and related metabolites, such as γ-guanidinobutyric acid, and an age-dependent downregulation of cerebral γ-aminobutyric acid receptors. These findings indicate impaired γ-aminobutyric acid and γ-aminobutyric acid sub-type A (GABA) receptor signalling as major factors underlying the pathophysiology of this neurometabolic disorder. We studied the cortical oscillation patterns and their relationship with γ-aminobutyric acid metabolism in 18 children affected by this condition and 10 healthy controls. Using high-density EEG, we recorded somatosensory cortical responses and resting-state activity. Using electrical source imaging, we estimated the relative power changes (compared with baseline) in both stimulus-evoked and stimulus-induced responses for physiologically relevant frequency bands and resting-state power. Stimulus-evoked oscillations are phase locked to the stimulus, whereas induced oscillations are not. Power changes for both evoked and induced responses as well as resting-state power were correlated with plasma γ-aminobutyric acid and γ-guanidinobutyric acid concentrations and with cortical γ-aminobutyric acid measured by proton magnetic resonance spectroscopy. Plasma γ-aminobutyric acid, γ-guanidinobutyric acid and cortical γ-aminobutyric acid were higher in patients than in controls ( < 0.001 for both). Beta and gamma relative power were suppressed for evoked responses in patients versus controls ( < 0.01). No group differences were observed for induced activity ( > 0.05). The mean gamma frequency of evoked responses was lower in patients versus controls ( = 0.002). Resting-state activity was suppressed in patients for theta ( = 0.011) and gamma ( < 0.001) bands. Evoked power changes were inversely correlated with plasma γ-aminobutyric acid and with γ-guanidinobutyric acid for beta ( < 0.001) and gamma ( < 0.001) bands. Similar relationships were observed between the evoked power changes and cortical γ-aminobutyric acid for all tested areas in the beta band ( < 0.001) and for the posterior cingulate gyrus in the gamma band ( < 0.001). We also observed a negative correlation between resting-state activity and plasma γ-aminobutyric acid and γ-guanidinobutyric acid for theta ( < 0.001; = 0.003), alpha ( = 0.003; = 0.02) and gamma ( = 0.02; = 0.01) bands. Our findings indicate that increased γ-aminobutyric acid concentration is associated with reduced sensory-evoked beta and gamma activity and impaired neuronal synchronization in patients with succinic semialdehyde dehydrogenase deficiency. This further elucidates the pathophysiology of this neurometabolic disorder and serves as a potential biomarker for therapeutic trials.

摘要

琥珀酸半醛脱氢酶缺乏症是一种罕见的常染色体隐性遗传的γ-氨基丁酸分解代谢障碍性疾病,表现为智力残疾、表达性失语、运动障碍、精神疾病和癫痫。琥珀酸半醛脱氢酶缺乏症患者的特征是γ-氨基丁酸及相关代谢产物(如γ-胍基丁酸)水平升高,以及大脑γ-氨基丁酸受体随年龄增长而下调。这些发现表明,γ-氨基丁酸和γ-氨基丁酸A亚型(GABA)受体信号受损是这种神经代谢紊乱病理生理学的主要因素。我们研究了18名受此病影响的儿童和10名健康对照者的皮质振荡模式及其与γ-氨基丁酸代谢的关系。我们使用高密度脑电图记录体感皮质反应和静息状态活动。通过电源成像,我们估计了生理相关频段的刺激诱发反应和刺激诱导反应以及静息状态功率的相对功率变化(与基线相比)。刺激诱发振荡与刺激锁相,而诱导振荡则不然。诱发反应和诱导反应的功率变化以及静息状态功率与血浆γ-氨基丁酸和γ-胍基丁酸浓度以及通过质子磁共振波谱测量的皮质γ-氨基丁酸相关。患者的血浆γ-氨基丁酸、γ-胍基丁酸和皮质γ-氨基丁酸均高于对照组(两者均<0.001)。与对照组相比,患者诱发反应的β和γ相对功率受到抑制(<0.01)。诱导活动未观察到组间差异(>0.05)。与对照组相比,患者诱发反应的平均γ频率较低(=0.002)。患者静息状态活动在θ频段(=0.011)和γ频段(<0.001)受到抑制。诱发功率变化与血浆γ-氨基丁酸以及β频段(<0.001)和γ频段(<0.001)的γ-胍基丁酸呈负相关。在β频段(<0.001)的所有测试区域以及γ频段的后扣带回(<0.001)中,诱发功率变化与皮质γ-氨基丁酸之间也观察到类似关系。我们还观察到静息状态活动与血浆γ-氨基丁酸和γ-胍基丁酸在θ频段(<0.001;=0.003)、α频段(=0.003;=0.02)和γ频段(=0.02;=0.01)呈负相关。我们的研究结果表明,γ-氨基丁酸浓度升高与琥珀酸半醛脱氢酶缺乏症患者感觉诱发的β和γ活动减少以及神经元同步受损有关。这进一步阐明了这种神经代谢紊乱的病理生理学,并可作为治疗试验的潜在生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cb3/10636566/4f515a9ab02f/fcad291_ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cb3/10636566/4f515a9ab02f/fcad291_ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cb3/10636566/4f515a9ab02f/fcad291_ga1.jpg

相似文献

1
Reduced evoked cortical beta and gamma activity and neuronal synchronization in succinic semialdehyde dehydrogenase deficiency, a disorder of γ-aminobutyric acid metabolism.琥珀酸半醛脱氢酶缺乏症(一种γ-氨基丁酸代谢紊乱疾病)中诱发的皮质β和γ活动以及神经元同步性降低。
Brain Commun. 2023 Oct 25;5(6):fcad291. doi: 10.1093/braincomms/fcad291. eCollection 2023.
2
The presence and severity of epilepsy coincide with reduced γ-aminobutyrate and cortical excitatory markers in succinic semialdehyde dehydrogenase deficiency.琥珀酸半醛脱氢酶缺乏症患者的γ-氨基丁酸和皮质兴奋性标志物减少,其存在和严重程度与这些标志物相关。
Epilepsia. 2023 Jun;64(6):1516-1526. doi: 10.1111/epi.17592. Epub 2023 Apr 4.
3
Delays in latencies of median-nerve evoked magnetic fields in patients with succinic semialdehyde dehydrogenase deficiency.琥珀酸半醛脱氢酶缺乏症患者的正中神经诱发电磁场潜伏期延迟。
Clin Neurophysiol. 2024 May;161:52-58. doi: 10.1016/j.clinph.2024.02.010. Epub 2024 Feb 16.
4
Succinic semialdehyde dehydrogenase deficiency: an inborn error of gamma-aminobutyric acid metabolism.琥珀酸半醛脱氢酶缺乏症:一种γ-氨基丁酸代谢的先天性疾病。
Clin Chim Acta. 1983 Sep 15;133(1):33-42. doi: 10.1016/0009-8981(83)90018-9.
5
Glymphatic dysfunction coincides with lower GABA levels and sleep disturbances in succinic semialdehyde dehydrogenase deficiency.琥珀酸半醛脱氢酶缺乏症患者的糖质分解功能障碍与 GABA 水平降低和睡眠障碍同时发生。
J Sleep Res. 2024 Aug;33(4):e14105. doi: 10.1111/jsr.14105. Epub 2023 Dec 26.
6
Inherited disorders of GABA metabolism.γ-氨基丁酸代谢的遗传性疾病。
J Inherit Metab Dis. 1993;16(4):704-15. doi: 10.1007/BF00711902.
7
Acute Infantile Encephalopathy as Presentation of Succinic Semialdehyde Dehydrogenase Deficiency.急性婴儿脑病作为琥珀酸半醛脱氢酶缺乏症的表现
Pediatr Neurol. 2016 May;58:113-5. doi: 10.1016/j.pediatrneurol.2015.10.009. Epub 2015 Nov 14.
8
A Randomized Controlled Trial of SGS-742, a γ-aminobutyric acid B (GABA-B) Receptor Antagonist, for Succinic Semialdehyde Dehydrogenase Deficiency.SGS-742 治疗琥珀酸半醛脱氢酶缺乏症的随机对照试验:一种 γ-氨基丁酸 B(GABA-B)受体拮抗剂。
J Child Neurol. 2021 Nov;36(13-14):1189-1199. doi: 10.1177/08830738211012804. Epub 2021 May 20.
9
Resting-state EEG gamma activity in children with attention-deficit/hyperactivity disorder.注意缺陷多动障碍儿童静息态脑电图γ活动。
Clin Neurophysiol. 2010 Nov;121(11):1871-7. doi: 10.1016/j.clinph.2010.04.022. Epub 2010 May 18.
10
Succinic Semialdehyde Dehydrogenase Deficiency琥珀酸半醛脱氢酶缺乏症

本文引用的文献

1
Autism spectrum disorder and GABA levels in children with succinic semialdehyde dehydrogenase deficiency.琥珀酸半醛脱氢酶缺乏症患儿的自闭症谱系障碍与 GABA 水平。
Dev Med Child Neurol. 2023 Dec;65(12):1596-1606. doi: 10.1111/dmcn.15659. Epub 2023 May 28.
2
Establishment and validation of a clinical severity scoring system for succinic semialdehyde dehydrogenase deficiency.琥珀酸半醛脱氢酶缺乏症临床严重程度评分系统的建立与验证
J Inherit Metab Dis. 2023 Sep;46(5):992-1003. doi: 10.1002/jimd.12635. Epub 2023 May 30.
3
The presence and severity of epilepsy coincide with reduced γ-aminobutyrate and cortical excitatory markers in succinic semialdehyde dehydrogenase deficiency.
琥珀酸半醛脱氢酶缺乏症患者的γ-氨基丁酸和皮质兴奋性标志物减少,其存在和严重程度与这些标志物相关。
Epilepsia. 2023 Jun;64(6):1516-1526. doi: 10.1111/epi.17592. Epub 2023 Apr 4.
4
A comprehensive guide to MEGA-PRESS for GABA measurement.MEGA-PRESS 用于 GABA 测量的综合指南。
Anal Biochem. 2023 May 15;669:115113. doi: 10.1016/j.ab.2023.115113. Epub 2023 Mar 21.
5
Ameliorates SD-Induced Stress Responses and Gut Dysbiosis by Increasing the Absorption of Gut-Derived GABA in Rhesus Monkeys.通过增加肠道衍生 GABA 的吸收缓解 SD 诱导的应激反应和肠道菌群失调。
Front Immunol. 2022 Jul 7;13:915393. doi: 10.3389/fimmu.2022.915393. eCollection 2022.
6
Intestinal Dysbiosis as a component of pathophysiology in succinic semialdehyde dehydrogenase deficiency (SSADHD).琥珀酸半醛脱氢酶缺乏症(SSADHD)发病生理机制中的肠道菌群失调。
Mol Genet Metab. 2022 Jan;135(1):42-46. doi: 10.1016/j.ymgme.2021.11.355. Epub 2021 Dec 3.
7
Magnetic Resonance Imaging (MRI) and Spectroscopy in Succinic Semialdehyde Dehydrogenase Deficiency.琥珀酸半醛脱氢酶缺乏症的磁共振成像(MRI)和光谱分析。
J Child Neurol. 2021 Nov;36(13-14):1162-1168. doi: 10.1177/0883073821991295. Epub 2021 Feb 9.
8
Measuring the effects of first antiepileptic medication in Temporal Lobe Epilepsy: Predictive value of quantitative-EEG analysis.测量颞叶癫痫中第一种抗癫痫药物的效果:定量脑电图分析的预测价值。
Clin Neurophysiol. 2021 Jan;132(1):25-35. doi: 10.1016/j.clinph.2020.10.020. Epub 2020 Nov 12.
9
The effects of antiepileptic drugs on high-frequency oscillations in somatosensory evoked potentials.抗癫痫药物对体感诱发电位高频振荡的影响。
Clin Neurophysiol. 2020 Aug;131(8):1917-1924. doi: 10.1016/j.clinph.2020.05.022. Epub 2020 Jun 12.
10
Resting-state EEG activity predicts frontoparietal network reconfiguration and improved attentional performance.静息态 EEG 活动可预测额顶网络的重新配置和注意力表现的改善。
Sci Rep. 2020 Mar 19;10(1):5064. doi: 10.1038/s41598-020-61866-7.